Soya protein reverses dyslipidaemia and the altered capacity of insulin-stimulated glucose utilization in the skeletal muscle of sucrose-rich diet-fed rats

British Journal of Nutrition

Volumn 102, Issue 1, 2009, Pages 60-68

  Oliva, María E ^a   Chicco, Adriana G ^a   Lombardo, Yolanda B ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Dyslipidaemia; Insulin resistance; Skeletal muscle; Soya protein

Indexed keywords

CARBOHYDRATE; CASEIN; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; LIPID; SOYBEAN PROTEIN; STARCH; SUCROSE; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CARBOHYDRATE DIET; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FATTY LIVER; GLUCOSE HOMEOSTASIS; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MAIZE; MALE; METABOLIC DISORDER; NONHUMAN; PROTEIN DIET; RAT; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; COMPARATIVE STUDY; GLUCOSE CLAMP TECHNIQUE; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; SUGAR INTAKE; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

ANIMALS; BIOLOGICAL MARKERS; CHOLESTEROL; DIETARY SUCROSE; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 69249232296     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508159013     Document Type: Article

References (40)

1. Cheal KL, Abbasi F, Lamendola C, et al. (2004) Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53, 1195-1200.
2. Food and Drug Administration (1999) Food labelling: Health claims; soy protein and coronary heart disease. Food and drug administration, HHS. Final rule. Fed Regist 64, 57700-57733.
3. Carroll KK & Kurowska EM (1995) Soy consumption and cholesterol reduction: Review of animal and human studies. J Nutr 125, 594-597.
4. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Metaanalysis of the effects of soy protein intake of serum lipids. N Engl J Med 333, 276-282.
5. Tovar AR, Torre-Villalvazo I, Ochoa M, et al. (2005) Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46, 1823-1832.
6. Ascencio C, Torres N, Isoard-Acosta F, et al. (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134, 522-529.
7. Mezei O, Banz WJ, Steger RW, et al. (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese zucker rats and murine RAW 264•7 cells. J Nutr 133, 1238-1243.
8. Morifuji M, Sanbongi C & Sugiura K (2006) Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats. Br J Nutr 96, 469-475.
9. Iritani N, Sugimoto T, Fukuda H, et al. (1997) Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 127, 1077-1083.
10. Sanchez A & Hubbard RW (1991) Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses 36, 27-32.
11. Sugano M, Ishiwaki N & Nakashira K (1984) Dietary proteindependent modification of serum cholesterol level in rat. Significance of the arginine/lysine ratio. Ann Nutr Metab 28, 192-199.
12. Taha SA & Wasif MM (1996) Hypoglycemic effect and protein nutritive quality of soy and methionine-supplemented whole durum pasta products. Nahrung 40, 281-287.
13. Davis J, Steinle J, Higginbotham DA, et al. (2005) Soy protein influences insulin sensitivity and cardiovascular risk in male lean SHHF rats. Horm Metab Res 37, 309-315.
14. Velásquez MT & Bhathena SJ (2007) Role of dietary soy protein in obesity. Int J Med Sci 4, 72-82.
15. Chicco A, Basabe JC, Karabatas L, et al. (2000) Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats. Metabolism 49, 1346-1351.
16. Fortino A, Lombardo YB & Chicco A (2007) The reduction of dietary sucrose improves dyslipidemia, adiposity and insulin secretion in an insulin-resistant rat model. Nutrition 23, 489-497.
17. Lombardo YB, Hein G & Chicco A (2007) Metabolic syndrome: Effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids 42, 427-437.
18. Pighin D, Karabatas L, Rossi A, et al. (2003) Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucrose-rich diet. J Nutr 133, 4095-4101.
19. Chicco A, D'Alessandro ME, Karabatas L, et al. (2003) Muscle lipid metabolism and insulin secretion are altered in insulinresistant rats fed a high sucrose diet. J Nutr 133, 127-133.
20. D'Alessandro ME, Chicco A & Lombardo YB (2006) A long sucrose-rich diet increases triacylglycerol content and membrane nPKCu expression and alters glucose metabolism in skeletal muscle of rat. Nutr Res 26, 289-296.
21. Lavigne C, Marette A & Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278, E491-E500.
22. Pfeuffer M & Barth CA (1992) Dietary sucrose but not starch promotes protein-induced differences in rates of VLDL secretion and plasma lipid concentrations in rats. J Nutr 122, 1582-1586.
23. Chicco AG, D'Alessandro ME, Hein GJ, et al. (2008) Dietary chia seed (Salvia hispanica L.) rich in a-linolenic acid improves adiposity and normalises hypertriacylglycerolaemia and insulin resistance in dyslipidaemic rats. Br J Nutr (Epublication ahead of print version 20 May 2008).
24. Herbert V, Lau KS, Gottlierb CH, et al. (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25, 1375-1384.
25. Lombardo YB, Chicco A, Basilico MZ, et al. (1985) Effect of brominated vegetable oils on heart lipid metabolism. Lipids 20, 425-432.
26. Lombardo YB, Chicco A, D'Alessandro ME, et al. (1996) Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim Biophys Acta 1299, 175-182.
27. Rössner S (1974) Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid. Acta Med Scand Suppl 564, 1-24.
28. D'Alessandro ME, Chicco A, Karabatas L, et al. (2000) Role of skeletal muscle on impaired insulin sensitivity in rats fed a sucrose-rich diet: Effect of moderate levels of dietary fish oil. J Nutr Biochem 11, 273-280.
29. Soria A, D'Alessandro ME & Lombardo YB (2001) Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes. J Appl Physiol 91, 2109-2116.
30. Snedecor GWP & Cochran WG (1967) Statistical Methods. Ames: Iowa State University Press.
31. Sugano M, Tanaka K & Ide T (1982) Secretion of cholesterol, triglyceride and apolipoprotein A-I by isolated perfused liver from rats fed soybean protein and casein or their amino acid mixtures. J Nutr 112, 855-862.
32. Pfeuffer M & Barth CA (1986) Modulation of very low-density lipoprotein secretion by dietary protein is age-dependent in rats. Ann Nutr Metab 30, 281-288.
33. Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125, 3 Suppl., 606S-611S.
34. Ali AA, Velasquez MT, Hansen CT, et al. (2005) Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J Nutr Biochem 16, 693-699.
35. Demonty I, Lamarche B, Deshaies Y, et al. (2002) Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem 13, 671-677.
36. Tovar AR, Ascencio C & Torres N (2002) Soy protein, casein, and zein regulate histidase gene expression by modulating serum glucagon. Am J Physiol Endocrinol Metab 283, E1016-E1022.
37. Torres N, Torre-Villalvazo I & Tovar AR (2006) Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 17, 365-373.
38. Torre-Villalvazo I, Tovar AR, Ramos-Barragán VE, et al. (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138, 462-468.
39. Iritani N, Hosomi H, Fukuda H, et al. (1996) Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J Nutr 126, 380-388.
40. Randle PJ (1999) Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263-283.